Pharmaceutical Equipment Qualification Case Study

REPHINE SPEECH MARKS OPEN DIGITALISATION

Every qualification project is an opportunity to simplify complexity. By combining regulatory rigour with operational insight, we help our clients turn compliance into a competitive advantage.   

~Rephine Qualification Lead Consultant

REPHINE SPEECH MARKS CLOSE DIGITALISATION

About this Case Study

In this case study, we explore how Rephine partnered with a global pharmaceutical manufacturer to qualify both new and legacy equipment at a renovated thyroid API production facility. With complex systems, tight regulatory deadlines, and internal resource constraints, the client required a practical, compliant strategy to restart operations without delays.

Rephine’s qualification experts implemented a risk-based approach aligned with GMP and Annex 15 guidelines, enabling the client to:

  • Streamline IQ/OQ execution by integrating supplier testing
  • Reduce documentation workload through modular, reusable protocols
  • Improve traceability and process consistency across systems
  • Pass internal audits with zero observations
  • Establish a framework for future requalification

Over a six-month period, Rephine helped the site achieve full GMP compliance while significantly accelerating the equipment qualification timeline—delivering measurable value from day one.

Download the full case study to see how Rephine transformed complex qualification challenges into a scalable, compliant, and time-saving solution.

Equipment qualification Case Study mock up

Download the Case Study

View other our other resources and company news

BANNER Practical Guide to Post Market Surveillance PMS under EU MDR IVDR Guide

Practical Guide to Post-Market Surveillance (PMS) under EU MDR/IVDR

The EU’s new Product Liability Directive (2024/2853) changes who can be held liable and what damages can be claimed. From software and data loss to ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

AI for Pharmaceutical SOPs: Transforming Quality Management and Compliance

Rephine helps pharmaceutical and biotech companies transition to digital QMS platforms like Veeva Vault, MasterControl, or TrackWise. From vendor-neutral selection to full GxP-compliant validation and ...
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan CAPA

Strengthening CAPA & Exceptions Management

Learn how Rephine’s tailored GxP training helped a pharmaceutical manufacturer strengthen CAPA effectiveness, improve compliance, and boost team confidence.
Read More
GMP Raising the bar Blog series Header image May 25 Blog

EU GMP Annex 1 vs FDA Aseptic Guide: Bridging Compliance

EU and U.S. regulators share the same sterility assurance goals, but their approaches differ. Learn how to align Annex 1 and FDA guidance to streamline ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

GMP & GDP: Ensuring Quality in Drug Storage and Transport

Storage and transport aren’t just logistics — they’re critical GMP processes. Discover how USP helps pharma companies manage risk and maintain quality across global ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

Blockchain for GMP Documentation: Hype or Future Reality?

Blockchain promises immutability, traceability, and transparency for GMP documentation. But is it a compliance game-changer — or just hype?
Read More
Medical Device Guide

Is Your Insurance Policy Ready for the New EU Product Liability Directive?

The EU’s new Product Liability Directive (2024/2853) changes who can be held liable and what damages can be claimed. From software and data loss to ...
Read More
News update: 100% drug tariffs in the USA impacting pharmaceutical supply chains and compliance Article

100% Drug Tariffs in the U.S. – Impact on Pharma Supply Chains & Compliance

The U.S. has announced sweeping 100% tariffs on patented medicines, disrupting pharma supply chains and market access. Discover what this means for manufacturers — and ...
Read More
CSV Blog

Data Governance & AI in Pharma | Ensuring Trust & Compliance

In an age where AI promises transformation across pharma, success hinges on one factor: data you can trust. Explore how rigorous governance, quality control, and ...
Read More
Contact Us

Strengthen Your Assurance Journey

GMP Chapter 22 Adapting to Hybrid Documentation Standards